NVS
Price:
$98.35
Market Cap:
$190.57B
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients an...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1996-11-07
Stock Exchange
NYSE
Ticker
NVS
According to Novartis AG’s latest financial reports and current stock price. The company's current ROE is 41.08%. This represents a change of 309.94% compared to the average of 10.02% of the last 4 quarters.
The mean historical ROE of Novartis AG over the last ten years is 17.91%. The current 41.08% ROE has changed 129.39% with respect to the historical average. Over the past ten years (40 quarters), NVS's ROE was at its highest in in the December 2021 quarter at 24.10%. The ROE was at its lowest in in the December 2016 quarter at 1.28%.
Average
17.91%
Median
14.34%
Minimum
8.97%
Maximum
35.51%
Discovering the peaks and valleys of Novartis AG ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 171.51%
Maximum Annual ROE = 35.51%
Minimum Annual Increase = -66.99%
Minimum Annual ROE = 8.97%
Year | ROE | Change |
---|---|---|
2023 | 31.82% | 171.51% |
2022 | 11.72% | -66.99% |
2021 | 35.51% | 148.95% |
2020 | 14.26% | 10.70% |
2019 | 12.88% | -19.69% |
2018 | 16.04% | 54.46% |
2017 | 10.39% | 15.79% |
2016 | 8.97% | -61.14% |
2015 | 23.08% | 59.98% |
2014 | 14.43% | 16.91% |
The current ROE of Novartis AG (NVS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
26.35%
5-year avg
21.24%
10-year avg
17.91%
Novartis AG’s ROE is less than AstraZeneca PLC (16.57%), less than GSK plc (18.08%), less than Roche Holding AG (36.46%), greater than Bristol-Myers Squibb Company (-36.26%), less than Sanofi (6.13%), less than Merck & Co., Inc. (29.27%), greater than Bayer Aktiengesellschaft (-2.61%), less than Gilead Sciences, Inc. (0.65%), less than Johnson & Johnson (20.94%), less than AbbVie Inc. (65.72%), less than Eli Lilly and Company (65.15%), less than Pfizer Inc. (4.72%),
Company | ROE | Market cap |
---|---|---|
16.57% | $205.57B | |
18.08% | $69.43B | |
36.46% | $225.56B | |
-36.26% | $117.15B | |
6.13% | $120.51B | |
29.27% | $251.57B | |
-2.61% | $19.06B | |
0.65% | $117.09B | |
20.94% | $351.15B | |
65.72% | $317.73B | |
65.15% | $755.34B | |
4.72% | $151.34B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novartis AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Novartis AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Novartis AG's ROE?
How is the ROE calculated for Novartis AG (NVS)?
What is the highest ROE for Novartis AG (NVS)?
What is the 3-year average ROE for Novartis AG (NVS)?
What is the 5-year average ROE for Novartis AG (NVS)?
How does the current ROE for Novartis AG (NVS) compare to its historical average?